Evidence map›Paper›PMID 33775997›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massiliense.

Keisuke Oka, Hiroshi Morioka, Motoki Eguchi, Yoshitaka Sato, Nobuyuki Tetsuka, Mitsutaka Iguchi, Takeshi Kanematsu, Hanako Fukano, Yoshihiko Hoshino, Hitoshi Kiyoi and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Sitafloxacin Expresses Potent Anti-Frontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Keisuke OkaDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Hiroshi MoriokaDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Motoki EguchiDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Japan.
Yoshitaka SatoDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Nobuyuki TetsukaDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Mitsutaka IguchiDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Takeshi KanematsuDepartment of Clinical Laboratory, Nagoya University Hospital, Japan.
Hanako FukanoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Japan.
Yoshihiko HoshinoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Japan.
Hitoshi KiyoiDepartment of Hematology, Nagoya University Hospital, Japan.
Tetsuya YagiDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Nagoya University Hospital · JPNational Institute of Infectious Diseases · JPKyoto first Red Cross hospital · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a 59-year-old woman with a 2-year history of chronic bursitis of the hand who took 50 mg/day prednisolone for several autoimmune diseases. Mycobacteroides abscessus subsp. massiliense was isolated from the abscess and blood culture. Combination therapy (imipenem/cilastatin, amikacin, and clarithromycin) was administered for a month. Two months later, M. massiliense was detected from a blood culture again, and disseminated lesions were found. Clarithromycin and sitafloxacin were administered following eight weeks of the same regimen. Six months after the diagnosis, M. massiliense was isolated from a blood culture, and she expired due to multiple organ failure.

Indexed as

BacteremiaBursitisMycobacterium abscessusMycobacterium Infections, NontuberculousAnti-Bacterial AgentsClarithromycinFemaleHumansMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsClarithromycinbacteremiabursitisdisseminated infectionMycobacterium abscessus

Identifiers

PMID33775997
PMCPMC8502645
OpenAlexW3147289093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.